{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:07:09Z","timestamp":1792058829033,"version":"4.4.0"},"reference-count":86,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI161845"],"award-info":[{"award-number":["AI161845"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI131669"],"award-info":[{"award-number":["AI131669"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI140726"],"award-info":[{"award-number":["AI140726"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI141178"],"award-info":[{"award-number":["AI141178"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI133219"],"award-info":[{"award-number":["AI133219"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI134568"],"award-info":[{"award-number":["AI134568"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI140406"],"award-info":[{"award-number":["AI140406"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI140491"],"award-info":[{"award-number":["AI140491"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"John D. Stobo, the M.D. Distinguished Chair Endowment Fund at UTMB","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"University of Arizona College of Pharmacy faculty startup fund","award":["NA"],"award-info":[{"award-number":["NA"]}]},{"name":"R. Ken and Donna Coit Endowed Chair fund in Drug Discovery","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Flaviviruses cause a significant amount of mortality and morbidity, especially in regions where they are endemic. A recent example is the outbreak of Zika virus throughout the world. Development of antiviral drugs against different viral targets is as important as the development of vaccines. During viral replication, a single polyprotein precursor (PP) is produced and further cleaved into individual proteins by a viral NS2B-NS3 protease complex together with host proteases. Flavivirus protease is one of the most attractive targets for development of therapeutic antivirals because it is essential for viral PP processing, leading to active viral proteins. In this review, we have summarized recent development in drug discovery targeting the NS2B-NS3 protease of flaviviruses, especially Zika, dengue, and West Nile viruses.<\/jats:p>","DOI":"10.3390\/pathogens11030293","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T20:48:33Z","timestamp":1645994913000},"page":"293","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Antiviral Agents against Flavivirus Protease: Prospect and Future Direction"],"prefix":"10.3390","volume":"11","author":[{"given":"Subodh K.","family":"Samrat","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, 1703 E Mabel St, Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8245-7263","authenticated-orcid":false,"given":"Jimin","family":"Xu","sequence":"additional","affiliation":[{"name":"Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, 1703 E Mabel St, Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2811-1090","authenticated-orcid":false,"given":"Jia","family":"Zhou","sequence":"additional","affiliation":[{"name":"Chemical Biology Program, Department of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, TX 77555, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8684-5308","authenticated-orcid":false,"given":"Hongmin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, 1703 E Mabel St, Tucson, AZ 85721, USA"},{"name":"BIO5 Institute, The University of Arizona, Tucson, AZ 85721, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/s41564-020-0714-0","article-title":"The continued threat of emerging flaviviruses","volume":"5","author":"Pierson","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"R1258","DOI":"10.1016\/j.cub.2016.09.029","article-title":"Flaviviruses","volume":"26","author":"Best","year":"2016","journal-title":"Curr. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Li, Z., Zhang, J., and Li, H. (2017). Flavivirus NS2B\/NS3 Protease: Structure, Function, and Inhibition. Viral Proteases and Their Inhibitors, Elsevier Inc.","DOI":"10.1016\/B978-0-12-809712-0.00007-1"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s12250-013-3390-x","article-title":"The flavivirus protease as a target for drug discovery","volume":"28","author":"Brecher","year":"2013","journal-title":"Virol. Sin."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00705-021-05298-2","article-title":"Mammalian animal models for dengue virus infection: A recent overview","volume":"167","author":"Kayesh","year":"2021","journal-title":"Arch. Virol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/0470058005.ch2","article-title":"Dengue\/dengue haemorrhagic fever: History and current status","volume":"277","author":"Gubler","year":"2006","journal-title":"Novartis Found. Symp."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1756-3305-3-35","article-title":"Emergence of zoonotic arboviruses by animal trade and migration","volume":"3","author":"Pfeffer","year":"2010","journal-title":"Parasites Vectors"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1126\/science.350.6264.1012","article-title":"INFECTIOUS DISEASES. An obscure mosquito-borne disease goes global","volume":"350","author":"Enserink","year":"2015","journal-title":"Science"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Holbrook, M. (2017). Historical Perspectives on Flavivirus Research. Viruses, 9.","DOI":"10.3390\/v9050097"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/nm1144","article-title":"Emerging flaviviruses: The spread and resurgence of Japanese encephalitis, West Nile and dengue viruses","volume":"10","author":"Mackenzie","year":"2004","journal-title":"Nat. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.3390\/v5123088","article-title":"West Nile Virus in the United States\u2014A Historical Perspective","volume":"5","author":"Roehrig","year":"2013","journal-title":"Viruses"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41586-018-0446-y","article-title":"The emergence of Zika virus and its new clinical syndromes","volume":"560","author":"Pierson","year":"2018","journal-title":"Nature"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Brecher, M., Li, Z., Liu, B., Zhang, J., Koetzner, C.A., Alifarag, A., Jones, S.A., Lin, Q., Kramer, L.D., and Li, H. (2017). A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006411"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1053\/jinf.2001.0802","article-title":"Dengue and other emerging flaviviruses","volume":"42","author":"Solomon","year":"2001","journal-title":"J. Infect."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Norshidah, H., Vignesh, R., and Lai, N.S. (2021). Updates on Dengue Vaccine and Antiviral: Where Are We Heading?. Molecules, 26.","DOI":"10.3390\/molecules26226768"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41591-021-01282-0","article-title":"Developing therapeutic approaches for twenty-first-century emerging infectious viral diseases","volume":"27","author":"Meganck","year":"2021","journal-title":"Nat. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Zhao, R., Wang, M., Cao, J., Shen, J., Zhou, X., Wang, D., and Cao, J. (2021). Flavivirus: From Structure to Therapeutics Development. Life, 11.","DOI":"10.3390\/life11070615"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3390\/v3091739","article-title":"Functional RNA Elements in the Dengue Virus Genome","volume":"3","author":"Gebhard","year":"2011","journal-title":"Viruses"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13567-021-00966-2","article-title":"Structure and function of capsid protein in flavivirus infection and its applications in the development of vaccines and therapeutics","volume":"52","author":"Zhang","year":"2021","journal-title":"Vet. Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Obi, J.O., Guti\u00e9rrez-Barbosa, H., Chua, J.V., and Deredge, D.J. (2021). Current Trends and Limitations in Dengue Antiviral Research. Trop. Med. Infect. Dis, 6.","DOI":"10.20944\/preprints202108.0364.v1"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2009.11.009","article-title":"Structure and functionality in flavivirus NS-proteins: Perspectives for drug design","volume":"87","author":"Bollati","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1590\/S1415-47572010000200002","article-title":"NS3 protease from flavivirus as a target for designing antiviral inhibitors against dengue virus","volume":"33","author":"Natarajan","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"12895","DOI":"10.1128\/JVI.00942-09","article-title":"Crystal structure of a novel conformational state of the flavivirus NS3 protein: Implications for polyprotein processing and viral replication","volume":"83","author":"Assenberg","year":"2009","journal-title":"J. Virol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1128\/JCM.39.4.1264-1271.2001","article-title":"High-throughput detection of West Nile virus RNA","volume":"39","author":"Shi","year":"2001","journal-title":"J. Clin. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/cr.2016.116","article-title":"Mechanisms of activation and inhibition of Zika virus NS2B-NS3 protease","volume":"26","author":"Chen","year":"2016","journal-title":"Cell Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1073\/pnas.87.22.8898","article-title":"Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein","volume":"87","author":"Chambers","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1099\/vir.0.82735-0","article-title":"Yellow fever virus NS3 protease: Peptide-inhibition studies","volume":"88","author":"Knox","year":"2007","journal-title":"J. Gen. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1074\/jbc.M409931200","article-title":"Site-directed mutagenesis and kinetic studies of the West Nile Virus NS3 protease identify key enzyme-substrate interactions","volume":"280","author":"Chappell","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/jvi.65.5.2467-2475.1991","article-title":"Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins","volume":"65","author":"Falgout","year":"1991","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1128\/jvi.66.3.1535-1542.1992","article-title":"Cleavage of the dengue virus polyprotein at the NS3\/NS4A and NS4B\/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A\/NS4B may be processed by a cellular protease","volume":"66","author":"Cahour","year":"1992","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1099\/0022-1317-76-3-573","article-title":"Processing of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous proteases","volume":"76","author":"Jan","year":"1995","journal-title":"J. Gen. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.virol.2004.07.004","article-title":"The RNA helicase, nucleotide 5\u2019-triphosphatase, and RNA 5\u2019-triphosphatase activities of Dengue virus protein NS3 are Mg2+-dependent and require a functional Walker B motif in the helicase catalytic core","volume":"328","author":"Benarroch","year":"2004","journal-title":"Virology"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Van Den Elsen, K., Quek, J.P., and Luo, D. (2021). Molecular Insights into the Flavivirus Replication Complex. Viruses, 13.","DOI":"10.3390\/v13060956"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"30715","DOI":"10.1074\/jbc.272.49.30715","article-title":"Cotranslational Membrane Insertion of the Serine Proteinase Precursor NS2B-NS3(Pro) of Dengue Virus Type 2 Is Required for Efficient in Vitro Processing and Is Mediated through the Hydrophobic Regions of NS2B","volume":"272","author":"Clum","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"10278","DOI":"10.1128\/JVI.79.16.10278-10288.2005","article-title":"Structure of the Dengue Virus Helicase\/Nucleoside Triphosphatase Catalytic Domain at a Resolution of 2.4 A\u030a","volume":"79","author":"Xu","year":"2005","journal-title":"J. Virol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2008.07.001","article-title":"Towards the design of antiviral inhibitors against flaviviruses: The case for the multifunctional NS3 protein from Dengue virus as a target","volume":"80","author":"Lescar","year":"2008","journal-title":"Antivir. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.virol.2007.12.018","article-title":"Crystal structure of the catalytic domain of Japanese encephalitis virus NS3 helicase\/nucleoside triphosphatase at a resolution of 1.8 A","volume":"373","author":"Yamashita","year":"2008","journal-title":"Virology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"12891","DOI":"10.1074\/jbc.M112.442723","article-title":"NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex","volume":"288","author":"Kim","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pep.2015.11.022","article-title":"Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain","volume":"119","author":"Shannon","year":"2016","journal-title":"Protein Expr. Purif."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BSR20100142","article-title":"Dengue protease activity: The structural integrity and interaction of NS2B with NS3 protease and its potential as a drug target","volume":"31","author":"Phong","year":"2011","journal-title":"Biosci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-981-10-8727-1_10","article-title":"The Structure of the Zika Virus Protease, NS2B\/NS3(pro)","volume":"1062","author":"Hilgenfeld","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jviromet.2003.09.001","article-title":"Activation of dengue protease autocleavage at the NS2B-NS3 junction by recombinant NS3 and GST-NS2B fusion proteins","volume":"114","author":"Wu","year":"2003","journal-title":"J. Virol. Methods"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/cmdc.202000464","article-title":"Broad-Spectrum Flavivirus Inhibitors: A Medicinal Chemistry Point of View","volume":"15","author":"Felicetti","year":"2020","journal-title":"ChemMedChem"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.antiviral.2009.10.003","article-title":"Fifteen years of HIV Protease Inhibitors: Raising the barrier to resistance","volume":"85","author":"Wensing","year":"2010","journal-title":"Antivir. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1021\/acs.jmedchem.5b01697","article-title":"Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV\/AIDS","volume":"59","author":"Ghosh","year":"2016","journal-title":"J. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.2174\/0929867023368890","article-title":"HIV protease inhibitors: Peptidomimetic drugs and future perspectives","volume":"9","author":"Youssef","year":"2002","journal-title":"Curr. Med. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/infdis\/jis761","article-title":"Antiviral Resistance and the Future Landscape of Hepatitis C Virus Infection Therapy","volume":"207","author":"Wyles","year":"2013","journal-title":"J. Infect. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.apsb.2015.09.008","article-title":"Direct anti-HCV agents","volume":"6","author":"Zhang","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"16999","DOI":"10.1021\/acsomega.9b02491","article-title":"Discovery of New Inhibitors of Hepatitis C Virus NS3\/4A Protease and Its D168A Mutant","volume":"4","author":"Meewan","year":"2019","journal-title":"ACS Omega"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1021\/cb400100g","article-title":"Evaluating the role of macrocycles in the susceptibility of hepatitis C virus NS3\/4A protease inhibitors to drug resistance","volume":"8","author":"Ali","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1021\/acsinfecdis.6b00131","article-title":"Dengue Protease Substrate Recognition: Binding of the Prime Side","volume":"2","author":"Lin","year":"2016","journal-title":"ACS Infect. Dis."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1021\/bi2018267","article-title":"Structural Platform for the Autolytic Activity of an Intact NS2B\u2013NS3 Protease Complex from Dengue Virus","volume":"51","author":"Choksupmanee","year":"2012","journal-title":"Biochemistry"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pep.2013.09.015","article-title":"Lyso-myristoyl phosphatidylcholine micelles sustain the activity of Dengue non-structural (NS) protein 3 protease domain fused with the full-length NS2B","volume":"92","author":"Huang","year":"2013","journal-title":"Protein Expr. Purif."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nsmb1073","article-title":"Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus","volume":"13","author":"Erbel","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/JVI.06225-11","article-title":"Ligand-Bound Structures of the Dengue Virus Protease Reveal the Active Conformation","volume":"86","author":"Noble","year":"2012","journal-title":"J. Virol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1099\/vir.0.2008\/004606-0","article-title":"The multifunctional NS1 protein of influenza A viruses","volume":"89","author":"Hale","year":"2008","journal-title":"J. Gen. Virol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"13708","DOI":"10.1128\/JVI.78.24.13708-13716.2004","article-title":"Identification of residues in the dengue virus type 2 NS2B cofactor that are critical for NS3 protease activation","volume":"78","author":"Niyomrattanakit","year":"2004","journal-title":"J. Virol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrd.2017.33","article-title":"Broad-spectrum agents for flaviviral infections: Dengue, Zika and beyond","volume":"16","author":"Boldescu","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/978-981-10-8727-1_13","article-title":"Strategies Towards Protease Inhibitors for Emerging Flaviviruses","volume":"1062","author":"Nitsche","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.antiviral.2017.07.007","article-title":"Structure-based discovery of clinically approved drugs as Zika virus NS2B-NS3 protease inhibitors that potently inhibit Zika virus infection in vitro and in vivo","volume":"145","author":"Yuan","year":"2017","journal-title":"Antivir. Res."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Pathak, N., Lai, M.L., Chen, W.Y., Hsieh, B.W., Yu, G.Y., and Yang, J.M. (2017). Pharmacophore anchor models of flaviviral NS3 proteases lead to drug repurposing for DENV infection. BMC Bioinform., 18.","DOI":"10.1186\/s12859-017-1957-5"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejmech.2019.07.007","article-title":"Cell-active carbazole derivatives as inhibitors of the zika virus protease","volume":"180","author":"Rassias","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"31365","DOI":"10.1073\/pnas.2005463117","article-title":"Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors","volume":"117","author":"Abrams","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"105074","DOI":"10.1016\/j.antiviral.2021.105074","article-title":"Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors","volume":"190","author":"Akaberi","year":"2021","journal-title":"Antivir. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/aps.2015.56","article-title":"Policresulen, a novel NS2B\/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells","volume":"36","author":"Wu","year":"2015","journal-title":"Acta Pharm. Sin."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1016\/j.bmcl.2017.05.027","article-title":"Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity","volume":"27","author":"Takagi","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"9354","DOI":"10.1021\/acs.jmedchem.5b01441","article-title":"Discovery of Nanomolar Dengue and West Nile Virus Protease Inhibitors Containing a 4-Benzyloxyphenylglycine Residue","volume":"58","author":"Behnam","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"e00045-17","DOI":"10.1128\/JVI.00045-17","article-title":"Dengue Virus NS2B\/NS3 Protease Inhibitors Exploiting the Prime Side","volume":"91","author":"Lin","year":"2017","journal-title":"J. Virol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejmech.2015.12.030","article-title":"Discovery of antiviral molecules for dengue: In silico search and biological evaluation","volume":"110","author":"Sztajer","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1016\/j.bmc.2015.07.012","article-title":"Dual inhibitors of the dengue and West Nile virus NS2B-NS3 proteases: Synthesis, biological evaluation and docking studies of novel peptide-hybrids","volume":"23","author":"Behnam","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1080\/14756366.2018.1506772","article-title":"Phosphonate inhibitors of West Nile virus NS2B\/NS3 protease","volume":"34","author":"Milewska","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"514313","DOI":"10.3389\/fphar.2020.514313","article-title":"Identification of Theaflavin-3,3\u2019-Digallate as a Novel Zika Virus Protease Inhibitor","volume":"11","author":"Cui","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.biocel.2006.10.025","article-title":"Characterization of the West Nile virus protease substrate specificity and inhibitors","volume":"39","author":"Mueller","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/cr.2017.88","article-title":"Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction","volume":"27","author":"Li","year":"2017","journal-title":"Cell Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/acsinfecdis.0c00052","article-title":"Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential","volume":"6","author":"Xu","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-422X-11-10","article-title":"Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model","volume":"11","author":"Shi","year":"2014","journal-title":"Virol. J."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.antiviral.2014.07.014","article-title":"Nitazoxanide: A first-in-class broad-spectrum antiviral agent","volume":"110","author":"Rossignol","year":"2014","journal-title":"Antivir. Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1080\/22221751.2020.1838954","article-title":"Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo","volume":"9","author":"Li","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.antiviral.2017.12.018","article-title":"Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease","volume":"150","author":"Li","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Li, Z., Xu, J., Lang, Y., Wu, X., Hu, S., Samrat, S., Tharappel, A., Kuo, L., Butler, D., and Song, Y. (2021). In vitro and in vivo characterization of erythrosin B and derivatives against Zika virus. Acta Pharm. Sin. B.","DOI":"10.1016\/j.apsb.2021.10.017"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1021\/acsinfecdis.0c00217","article-title":"JMX0207, a Niclosamide Derivative with Improved Pharmacokinetics, Suppresses Zika Virus Infection Both In Vitro and In Vivo","volume":"6","author":"Li","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6832","DOI":"10.1021\/jacs.9b02505","article-title":"Discovery, X-ray Crystallography and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease","volume":"141","author":"Yao","year":"2019","journal-title":"J. Am. Chem. Soc."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1021\/acs.jmedchem.0c02070","article-title":"Synthesis, Structure-Activity Relationships, and Antiviral Activity of Allosteric Inhibitors of Flavivirus NS2B-NS3 Protease","volume":"64","author":"Nie","year":"2021","journal-title":"J. Med. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Batool, F., Saeed, M., Saleem, H.N., Kirschner, L., and Bodem, J. (2021). Facile Synthesis and In Vitro Activity of N-Substituted 1,2-Benzisothiazol-3(2H)-ones against Dengue Virus NS2BNS3 Protease. Pathogens, 10.","DOI":"10.3390\/pathogens10040464"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1021\/acs.jmedchem.9b01697","article-title":"Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B\/NS3 Proteases","volume":"62","author":"Millies","year":"2019","journal-title":"J. Med. Chem."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/11\/3\/293\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:27:08Z","timestamp":1760135228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/11\/3\/293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":86,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["pathogens11030293"],"URL":"https:\/\/doi.org\/10.3390\/pathogens11030293","relation":{"has-preprint":[{"id-type":"doi","id":"10.20944\/preprints202201.0468.v1","asserted-by":"object"}]},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]}}}